Camp4 Therapeutics (CAMP) Enterprise Value (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Enterprise Value of -$99.9 million for Q1 2026, up 9.85% sequentially from -$110.9 million in Q4 2025, and down 102.72% YoY from $3.7 billion in Q1 2025.
Camp4 Therapeutics (CAMP) Enterprise Value (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Enterprise Value for 4 years, with the latest figure at -$99.9 million in Q1 2026.
- Quarterly Enterprise Value fell 102.72% year-over-year to -$99.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$99.9 million (down 102.72% YoY) and the FY2025 annual result came in at -$110.9 million, down 73.12% from the prior year.
- Enterprise Value grew to -$99.9 million in Q1 2026 per CAMP's latest filing, from -$110.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$2.5 million in Q3 2024 and troughed at -$110.9 million in Q4 2025.
- A 4-year average of -$58.9 million and a median of -$50.5 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 94.99% in 2024, then tumbled 2876.86% in 2025.
- Over 4 years, Enterprise Value stood at -$38.4 million in 2023, then slumped by 66.86% to -$64.0 million in 2024, then slumped by 73.12% to -$110.9 million in 2025, then climbed by 9.85% to -$99.9 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$99.9 million, -$110.9 million, and -$75.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | -87.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -87.13 Mn |
| Mar 31, 2026 | -99.94 Mn |
| Dec 31, 2025 | -110.86 Mn |
| Sep 30, 2025 | -75.26 Mn |
| Jun 30, 2025 | -39.05 Mn |
| Mar 31, 2025 | -49.30 Mn |
| Dec 31, 2024 | -64.04 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Dec 31, 2023 | -38.38 Mn |
| Sep 30, 2023 | -50.47 Mn |